4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-16-156835
CIK 0001510580operating
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:33 PM ET
Size
7.0 KB
Accession
0001209191-16-156835
Insider Transaction Report
Form 4
JENKINSON PAUL L
Chief Financial Officer
Transactions
- Award
Common Stock
2016-12-22+6,600→ 6,600 total - Award
Employee Stock Option (Right to Buy)
2016-12-22+24,200→ 24,200 totalExercise: $46.09Exp: 2026-12-22→ Common Stock (24,200 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on the first anniversary of the grant date, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:33 PM ET
- Size
- 7.0 KB